196 334. Wolk, B., B. Buchele, D. Moradpour, and C. M. Rice. 2008. A dynamic view <strong>of</strong> <strong>hepatitis</strong> C virus replication complexes. J Virol 82:10519-31. 335. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parol<strong>in</strong>, N. Ruff<strong>in</strong>g, A. Borsetti, A. A. Cardoso, E. Desjard<strong>in</strong>, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-<strong>in</strong>duced <strong>in</strong>teraction <strong>of</strong> primary HIV-1 gp120 glycoprote<strong>in</strong>s with the chemok<strong>in</strong>e <strong>receptor</strong> CCR-5. Nature 384:179-83. 336. Wunschmann, S., J. D. Medh, D. Kl<strong>in</strong>zmann, W. N. Schmidt, and J. T. Stapleton. 2000. Characterization <strong>of</strong> <strong>hepatitis</strong> C virus (HCV) and HCV E2 <strong>in</strong>teractions with CD81 and the low-density lipoprote<strong>in</strong> <strong>receptor</strong>. J Virol 74:10055-62. 337. Wunschmann, S., H. M. Muller, C. S. Stipp, M. E. Hemler, and J. T. Stapleton. 2006. In Vitro Interaction between Hepatitis C Virus (HCV) Envelope Glycoprote<strong>in</strong> E2 and Serum Lipoprote<strong>in</strong>s (LPs) Results <strong>in</strong> Enhanced Cellular B<strong>in</strong>d<strong>in</strong>g <strong>of</strong> Both HCV E2 and LPs. J Infect Dis 194:1058-67. 338. Wustner, D., M. Mondal, A. Huang, and F. R. Maxfield. 2004. Different transport routes for high density lipoprote<strong>in</strong> and its associated free sterol <strong>in</strong> polarized hepatic cells. J Lipid Res 45:427-37. 339. Yalaoui, S., T. Huby, J. F. Franetich, A. Gego, A. Rametti, M. Moreau, X. Collet, A. Siau, G. J. van Gemert, R. W. Sauerwe<strong>in</strong>, A. J. Luty, J. C. Vaillant, L. Hannoun, J. Chapman, D. Mazier, and P. Froissard. 2008. Scavenger <strong>receptor</strong> <strong>BI</strong> boosts hepatocyte permissiveness to Plasmodium <strong>in</strong>fection. Cell Host Microbe 4:283-92. 340. Yamashita, T., S. Kaneko, Y. Shirota, W. Q<strong>in</strong>, T. Nomura, K. Kobayashi, and S. Murakami. 1998. RNA-dependent RNA polymerase activity <strong>of</strong> the soluble recomb<strong>in</strong>ant <strong>hepatitis</strong> C virus NS5B prote<strong>in</strong> truncated at the C-term<strong>in</strong>al region. J Biol Chem 273:15479-86. 341. Yanagi, M., R. H. Purcell, S. U. Emerson, and J. Bukh. 1997. Transcripts from a s<strong>in</strong>gle full-length cDNA clone <strong>of</strong> <strong>hepatitis</strong> C virus are <strong>in</strong>fectious when directly transfected <strong>in</strong>to the liver <strong>of</strong> a chimpanzee. Proc Natl Acad Sci U S A 94:8738-43. 342. Yang, W., C. Qiu, N. Biswas, J. J<strong>in</strong>, S. C. Watk<strong>in</strong>s, R. C. Montelaro, C. B. Coyne, and T. Wang. 2008. Correlation <strong>of</strong> the tight junction-like distribution <strong>of</strong> Claud<strong>in</strong>-1 to the cellular tropism <strong>of</strong> <strong>hepatitis</strong> C virus. J Biol Chem 283:8643-53. 343. Ye, J. 2007. Reliance <strong>of</strong> host cholesterol metabolic pathways for the life cycle <strong>of</strong> <strong>hepatitis</strong> C virus. PLoS Pathog 3:e108. 344. Yi, M., R. A. Villanueva, D. L. Thomas, T. Wakita, and S. M. Lemon. 2006. Production <strong>of</strong> <strong>in</strong>fectious genotype 1a <strong>hepatitis</strong> C virus (Hutch<strong>in</strong>son stra<strong>in</strong>) <strong>in</strong> cultured human hepatoma cells. Proc Natl Acad Sci U S A 103:2310-5. 345. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Sh<strong>in</strong>obu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. <strong>The</strong> RNA helicase RIG-I has an essential function <strong>in</strong> double-stranded RNA<strong>in</strong>duced <strong>in</strong>nate antiviral responses. Nat Immunol 5:730-7. 346. Zeisel, M. B., G. Koutsoudakis, E. K. Schnober, A. Haberstroh, H. E. Blum, F. L. Cosset, T. Wakita, D. Jaeck, M. D<strong>of</strong>foel, C. Royer, E. Soulier, E. Schvoerer, C. Schuster, F. Stoll-Keller, R. Bartenschlager, T. Pietschmann, H. Barth, and T. F. Baumert.
197 2007. Scavenger <strong>receptor</strong> class B type I is a key host factor for <strong>hepatitis</strong> C virus <strong>in</strong>fection required for an entry step closely l<strong>in</strong>ked to CD81. Hepatology 46:1722-31. 347. Zennou, V., C. Serguera, C. Sarkis, P. Col<strong>in</strong>, E. Perret, J. Mallet, and P. Charneau. 2001. <strong>The</strong> HIV-1 DNA flap stimulates HIV vectormediated cell transduction <strong>in</strong> the bra<strong>in</strong>. Nat Biotechnol 19:446-50. 348. Zhang, J., G. Randall, A. Higg<strong>in</strong>bottom, P. Monk, C. M. Rice, and J. A. McKeat<strong>in</strong>g. 2004. CD81 is required for <strong>hepatitis</strong> C virus glycoprote<strong>in</strong>-mediated viral <strong>in</strong>fection. J Virol 78:1448-55. 349. Zhang, Y., A. M. Ahmed, N. McFarlane, C. Capone, D. R. Boreham, R. Truant, S. A. Igdoura, and B. L. Trigatti. 2007. Regulation <strong>of</strong> SR- <strong>BI</strong>-mediated selective lipid uptake <strong>in</strong> Ch<strong>in</strong>ese hamster ovary-derived cells by prote<strong>in</strong> k<strong>in</strong>ase signal<strong>in</strong>g pathways. J Lipid Res 48:405-16. 350. Zheng, A., F. Yuan, Y. Li, F. Zhu, P. Hou, J. Li, X. Song, M. D<strong>in</strong>g, and H. Deng. 2007. Claud<strong>in</strong>-6 and claud<strong>in</strong>-9 function as additional co<strong>receptor</strong>s for <strong>hepatitis</strong> C virus. J Virol 81:12465-71. 351. Zhong, J., P. Gastam<strong>in</strong>za, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust <strong>hepatitis</strong> C virus <strong>in</strong>fection <strong>in</strong> vitro. Proc Natl Acad Sci U S A 102:9294-9. 352. Zhong, J., P. Gastam<strong>in</strong>za, J. Chung, Z. Stamataki, M. Isogawa, G. Cheng, J. A. McKeat<strong>in</strong>g, and F. V. Chisari. 2006. Persistent <strong>hepatitis</strong> C virus <strong>in</strong>fection <strong>in</strong> vitro: coevolution <strong>of</strong> virus and host. J Virol 80:11082-93. 353. Zhu, H., H. Dong, E. Eksioglu, A. Hemm<strong>in</strong>g, M. Cao, J. M. Crawford, D. R. Nelson, and C. Liu. 2007. Hepatitis C virus triggers apoptosis <strong>of</strong> a newly developed hepatoma cell l<strong>in</strong>e through antiviral defense system. Gastroenterology 133:1649-59. 354. Zuckerman, A. J. 1989. <strong>The</strong> elusive <strong>hepatitis</strong> C virus. BMJ 299:871-3.
- Page 1 and 2:
The role of scavenger receptor B-I
- Page 3 and 4:
i Abstract. With 170 million infect
- Page 5 and 6:
iii Acknowledgements. I would like
- Page 7 and 8:
v 5 Results: Identification of a re
- Page 9 and 10:
vii Figure 5-5 Analysis of JFH-1 wt
- Page 11 and 12:
1 Introduction 1.1 The disease. 1 D
- Page 13 and 14:
3 predominantly immuno-pathogenic i
- Page 15 and 16:
5 Aside from considerations of the
- Page 17 and 18:
7 Current attempts to design a HCV
- Page 19 and 20:
1.2 An elusive pathogen. 9 The emer
- Page 21 and 22:
11 PCR). This technique is highly s
- Page 23 and 24:
13 Within six years of the descript
- Page 25 and 26:
1.3 Basic virology. 15 Like other m
- Page 27 and 28:
17 Figure 1-2 HCV genome and polypr
- Page 29 and 30:
19 241). E1 and E2 are anchored to
- Page 31 and 32:
21 The characterisation of HCV geno
- Page 33 and 34:
23 in the E1 and E2 glycoprotein ge
- Page 35 and 36:
25 The solution reached by a great
- Page 37 and 38:
27 binding to mouse cells. sE2 inte
- Page 39 and 40:
29 density lipoprotein (HDL), allow
- Page 41 and 42:
31 blood brain barrier is permeable
- Page 43 and 44:
33 act as receptors for viral entry
- Page 45 and 46:
1.4.2 Attachment factors 35 The tru
- Page 47 and 48:
1.4.3 Endocytosis and fusion 37 Aft
- Page 49 and 50:
39 1.4.4 Co-receptor interplay and
- Page 51 and 52:
41 inhibition of protein kinase A (
- Page 53 and 54:
1.5 Lipoproteins 43 Since 1992 ther
- Page 55 and 56:
45 Lipoproteins exist in a dynamic
- Page 57 and 58:
47 and delivers its cargo via the w
- Page 59 and 60:
49 uptake of cholesterol from LDL (
- Page 61 and 62:
Figure 1-4 SR-BI-lipoprotein intera
- Page 63 and 64:
53 In summary the class B scavenger
- Page 65 and 66:
55 In 1992 Thomssen et. al. demonst
- Page 67 and 68:
57 lipoprotein association promotes
- Page 69 and 70:
59 Figure 1-5 Lipo-viro-particle as
- Page 71 and 72:
61 In vitro culture medium, into wh
- Page 73 and 74:
2 Materials and methods. 2.1 Cell l
- Page 75 and 76:
Preparation of rat anti-E2 mAbs. 65
- Page 77 and 78:
2.4 Basic techniques. Flow cytometr
- Page 79 and 80:
69 6. Finally, the cells were washe
- Page 81 and 82:
71 (Promega, WI, USA) kits accordin
- Page 83 and 84:
73 proteins and are incapable of fu
- Page 85 and 86:
75 spectrophotometer (Amersham), we
- Page 87 and 88:
77 Figure 2-2 Electroporated Huh-7.
- Page 89 and 90:
79 5. Data is expressed as percenta
- Page 91 and 92:
81 (Invitrogen). The samples to be
- Page 93 and 94:
83 1. The SR-BII coding region was
- Page 95 and 96:
2.7 Cloning and synthesis of JFH-1
- Page 97 and 98:
The sequence encoding amino acids 3
- Page 99 and 100:
Figure 2-6 sE2 sequencing. 89 JFH-1
- Page 101 and 102:
91 7. Large scale transfections wer
- Page 103 and 104:
93 3 Results: Investigations using
- Page 105 and 106:
95 3.2 CHO cells expressing human S
- Page 107 and 108:
Figure 3-3 Ability of anti-E2 mAb t
- Page 109 and 110:
99 3.3 The interaction of sE2 with
- Page 111 and 112:
101 Figure 3-5 Position of SR-BI mu
- Page 113 and 114:
103 Table 3-2 Investigation of cell
- Page 115 and 116:
105 3.4 Expression of SR-BII in CHO
- Page 117 and 118:
3.5 Discussion. 107 We have demonst
- Page 119 and 120:
109 may offer a tool to study the i
- Page 121 and 122:
111 Figure 4-1A displays endogenous
- Page 123 and 124:
113 4.2 Exogenous expression of SR-
- Page 125 and 126:
115 4.3 Evidence of enhanced JFH-1
- Page 127 and 128:
117 4.4 SR-BI expression levels lim
- Page 129 and 130:
119 4.5 Murine SR-BI does not enhan
- Page 131 and 132:
121 4.6 SR-BI/II expression levels
- Page 133 and 134:
123 Figure 4-5 Over expression of S
- Page 135 and 136:
125 Figure 4-6 Anti-SR-BI serum inh
- Page 137 and 138:
127 Figure 4-7 Infection of Huh-7.5
- Page 139 and 140:
129 cells is largely manifested in
- Page 141 and 142:
131 5 Results: Identification of a
- Page 143 and 144:
133 Figure 5-1 JFH-1 G451R has an a
- Page 145 and 146:
135 Figure 5-2 CD81 dependence of J
- Page 147 and 148:
137 G451R sE2 with hCD81 LEL we com
- Page 149 and 150:
139 Figure 5-4 JFH-1 wt and G451R s
- Page 151 and 152:
141 demonstrated a lower dependence
- Page 153 and 154:
143 Figure 5-6 Relationship between
- Page 155 and 156: 145 flow cytometry (data not shown)
- Page 157 and 158: 147 5.6 Low density JFH-1 particles
- Page 159 and 160: 5.7 Discussion. 149 We have demonst
- Page 161 and 162: 151 Numerous reports have used dens
- Page 163 and 164: 153 demonstrate that low density JF
- Page 165 and 166: 155 to over express SR-BI we were a
- Page 167 and 168: 157 5-1), better able to engage CD8
- Page 169 and 170: 159 Figure 6-1 An overview of antib
- Page 171 and 172: 161 it is believed that ligation of
- Page 173 and 174: 163 Given our and other’s finding
- Page 175 and 176: 6.3 HCV lipo-viro-particles. 165 As
- Page 177 and 178: 167 represent the hyper-variable re
- Page 179 and 180: 169 The G451R mutation disrupts the
- Page 181 and 182: 7 Bibliography 171 1. Acton, S., D.
- Page 183 and 184: 173 include the CD81 tetraspanin an
- Page 185 and 186: 175 receptor class B type I and inh
- Page 187 and 188: 177 83. Drummer, H. E., K. A. Wilso
- Page 189 and 190: 179 KewalRamani, D. R. Littman, C.
- Page 191 and 192: 181 King. 1996. Efficient infection
- Page 193 and 194: 183 hepatitis C virus envelope glyc
- Page 195 and 196: 185 recovered chimpanzees exhibit r
- Page 197 and 198: 187 218. Monazahian, M., I. Bohme,
- Page 199 and 200: 189 243. Perez-Berna, A. J., J. Gui
- Page 201 and 202: 191 single-cycle production assay t
- Page 203 and 204: 193 298. Strickland, G. T., S. S. E
- Page 205: 195 Remaley, G. Csako, T. L. Eggerm